Skip to main content
. 2022 Jun 7;2022:1012813. doi: 10.1155/2022/1012813

Table 2.

Separate comparison of symptoms in the 2 groups of breast cancer patients before and after VR-CALM or CAU.

Group N FACT-B DT SAS SDS CARS PFS PSQI
VR-CALM group
 BCT 38 78.74 ± 10.125 5.71 ± 1.250 51.66 ± 11.252 51.32 ± 11.552 59.34 ± 13.581 103.03 ± 8.645 10.45 ± 3.438
 ACT 38 100.47 ± 14.33 2.95 ± 1.845 44.16 ± 11.083 46.63 ± 9.824 55.82 ± 10.557 77.79 ± 11.548 8.74 ± 2.565
t −10.379 11.521 4.680 4.101 2.742 9.913 6.066
p ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.01 ≤0.001 ≤0.001
CAU group
 BCT 39 75.44 ± 10.39 6.13 ± 0.695 49.31 ± 6.814 48.64 ± 4.934 55.00 ± 4.605 101.62 ± 9.35 10.05 ± 3.426
 ACT 39 79.44 ± 6.703 5.49 ± 1.393 55.21 ± 3.806 50.21 ± 3.806 53.49 ± 6.328 99.77 ± 6.964 11.26 ± 4.494
t −2.988 3.328 −4.817 −1.517 2.370 1.515 −1.839
p ≤0.01 ≤0.01 ≤0.001 0.138 ≤0.05 0.138 0.074

Note. FACT-B, Functional Assessment of Cancer Therapy-Breast cancer patient; DT, Distress Thermometer; SAS, The Self-Rating Anxiety Scale; SDS, The Self-Rating Depression Scale; CARS, Concerns About Recurrence Scale; PFS, Piper Fatigue Scale; PSQI, Pittsburgh Sleep Quality Index; BCT, before CALM/CAU treatment; ACT, after CALM/CAU treatment; SD, standard deviation. Data are presented as mean ± SD.